FOXO1 and metabolic dysfunction-associated steatotic liver disease: Thus, PRMT1, specifically the PRMT1V2 isoform, promotes the pathogenesis of NAFLD by methylating key transcriptional regulators such as PGC‐1α and FOXO1, thereby augmenting hepatic gluconeogenesis and exacerbating hyperglycemia.